Studies of efficacy of sustained-release buprenorphine in Sprague Dawley Rats

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Collection period

2019-01-01
2021-01-05

Date completed

2023-04-18

Date updated

Time period coverage

Geographic coverage

Source information

Journal Title

Journal ISSN

Volume Title

Title

Studies of efficacy of sustained-release buprenorphine in Sprague Dawley Rats

Published Date

2023-04-21

Author Contact

Fairbanks, Carolyn A
carfair@umn.edu

Type

Dataset
Experimental Data

Abstract

Buprenorphine in a sustained-release formulation is frequently administered to rats to provide extended analgesia without repeated handling. While levels of buprenorphine persist in serum once sustained-release buprenorphine has been introduced, exposure to opioids can cause opioid tolerance or opioid-induced hypersensitivity. This work examined the analgesic duration and efficacy of a single administration of sustained-release buprenorphine in models of inflammatory pain and post-operative pain and the development of opioid tolerance in rat. After subcutaneous administration of 1 mg/kg sustained-release buprenorphine, analgesic efficacy did not persist to 24 hours. No changes in mechanical thresholds in the hindpaws that were contralateral to the injury, suggesting a lack of centrally-mediated opioid-induced hypersensitivity. To determine whether opioid tolerance arose acutely after one exposure to sustained-release buprenorphine, we conducted the warm water tail flick assay; on Day 1 we administered either saline or sustained-release buprenorphine (1 mg/kg) and on Day 3 we quantified the standard buprenorphine dose-response curve (0.1 – 3 mg/kg). Rats previously given sustained-release buprenorphine displayed decreased analgesic responses after administration of standard buprenorphine as compared to the robust efficacy of standard buprenorphine in control subjects. Males appeared to show evidence of acute opioid tolerance, while females previously exposed to opioid did not demonstrate a decreased response at the doses examined. Taken together, these results suggest that opioid tolerance arises quickly in rats after exposure to the sustained-release formulation of buprenorphine. This tolerance may account for the brief period of antinociception observed.

Description

The data files included here are comprehensive reports of the behavioral data collected prior to (baseline) and following the administration of 1 mg/kg sustained release buprenorphine.

Referenced by

Related to

Replaces

Publisher

Funding information

The funding for this work was provided by the National Institute on Drug Abuse [award R01DA035931] and the National Institutes of Health [grant number 5T32 OD010993-14].

item.page.sponsorshipfunderid

item.page.sponsorshipfundingagency

item.page.sponsorshipgrant

Previously Published Citation

Suggested citation

Peterson, Cristina, D; Wilcox, George, L; Fairbanks, Carolyn, A; Kitto, Kelley, F; Larson, Christina, M. (2023). Studies of efficacy of sustained-release buprenorphine in Sprague Dawley Rats. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/253791.
View/Download file
File View/OpenDescriptionSize
Studies of Sustained-Release Buprenorphine Efficacy and Tolerance.xlsxAn Xcel file containing behavioral responses of Sprague Dawley rats following sustained-release buprenorphine in multiple models.21.09 KB

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.